Announce Phase 3 Clinical Trial Results For Interstitial Lung Disease Drug Krp-R120

Kyorin Pharmaceutical

16/09/2025 04:32

Kyorin Pharmaceutical Co Ltd 4569.T:

KYORIN PHARMACEUTICAL CO LTD - ANNOUNCE PHASE 3 CLINICAL TRIAL RESULTS FOR INTERSTITIAL LUNG DISEASE DRUG KRP-R120

Source text: ID:nTSup88443

Further company coverage: 4569.T